Shrewsbury, MA, United States of America

Ariel Orellana

This inventor holds 1 USPTO granted patent. Top assignee: University of Massachusetts. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ariel Orellana. Retrieved from https://idiyas.com/inventor/ariel-orellana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ariel Orellana: Innovator in Glycosaminoglycan Research

Introduction

Ariel Orellana is a notable inventor based in Shrewsbury, MA (US). She has made significant contributions to the field of biochemistry, particularly in the study of glycosaminoglycans. Her work focuses on the enzymatic processes that modify these important biomolecules.

Latest Patents

Ariel Orellana holds a patent for "Glycosaminoglycan specific sulfotransferases." This patent encompasses DNA encoding a polypeptide capable of catalyzing the deacetylation and sulfation of a glycosaminoglycan. It also includes the production and isolation of recombinant and synthetic polypeptides that can catalyze these processes. Additionally, the patent covers antibodies to the polypeptides of the invention and outlines therapeutic uses for these compounds.

Career Highlights

Ariel Orellana is affiliated with the University of Massachusetts, where she continues her research and innovation. Her work has garnered attention for its potential applications in medicine and biotechnology.

Collaborations

Ariel collaborates with esteemed colleagues, including Zheng Wei and Yasuhiro Hashimoto, who contribute to her research endeavors.

Conclusion

Ariel Orellana's innovative work in glycosaminoglycan research exemplifies the impact of scientific inquiry on health and medicine. Her contributions are paving the way for future advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…